Boehringer Ingelheim supports collaboration and knowledge sharing in the livestock industry Boehringer Ingelheim supports collaboration and knowledge sharing in the livestock industry Boehringer Ingelheim demonstrates its commitment to farm animal well-being by organising its 11th Expert Forum on Farm Animal Well-Being
The METAmorphosis The METAmorphosis At Boehringer Ingelheim’s META offices in the Middle East, Turkey and Africa all offices in the region are already free of single-use plastic.
The Unwearable Collection - The GPP patient experience The Unwearable Collection - The GPP patient experience The Unwearable Collection™ is a fashion line based on the experiences of patients living with generalized pustular psoriasis, designed by Bart Hess.
Bridging the gap in Generalized Pustular Psoriasis (GPP) Bridging the gap in Generalized Pustular Psoriasis (GPP) Emmanuelle Clerisme-Beaty, former Head of Clinical Development and Medical Affairs, Dermatology, discusses published insights from GPP patients.
Pulmonary Fibrosis: Early discovery makes all the difference Pulmonary Fibrosis: Early discovery makes all the difference Video taking a deep dive into pulmonary fibrosis. Visit an underwater world that brings to life the physical change PF has on the lungs.
Disentangling fibrosis Disentangling fibrosis Fibrosis is an important area of research for Boehringer Ingelheim that is focusing on fibrotic conditions of the liver, lung, kidney, skin and gut.
Biotherapeutics Discovery Biotherapeutics Discovery We are applying our deep understanding of disease biology to design a diverse range of novel modalities that are the foundation for life-changing biotherapeutics for patients.
FIBRONEER™ Ph3 trials in patients with IPF & other PF-ILDs FIBRONEER™ Ph3 trials in patients with IPF & other PF-ILDs Donald Zoz, M.D., Director and Senior Clinical Program Leader for Pulmonary Fibrosis, discusses the FIBRONEER™ global clinical program
Main Meal Main Meal You can browse through all of the filling main meal recipes from Taking Cancer on Through Flavour here.
GastroGard the first imported equine drug in China GastroGard the first imported equine drug in China GastroGard® approved as the first imported equine drug in China. Boehringer Ingelheim officially starts equine health business in China.
Every Drop Counts – Water Stewardship at Boehringer Ingelheim Every Drop Counts – Water Stewardship at Boehringer Ingelheim How we work actively to protect clean water and reduce our water footprint in all communities where we operate
The generalized pustular psoriasis (GPP) Forum 2023 The generalized pustular psoriasis (GPP) Forum 2023 An executive summary of the activities and key takeaways from the GPP Forum 2023
The GPP Charter The GPP Charter The GPP Charter defines a collaborative approach to identifying common goals for the GPP community
Yamagata Yamagata The site in Yamagata, Japan, is dedicated to the production of human pharmaceutical products for the Japanese market.
A tool to aid in the prevention of African swine fever A tool to aid in the prevention of African swine fever ASF COMBAT is an online management and biosecurity assessment tool aimed at reducing the African swine fever introduction risk level.
Winners of the 2019 European PRRS Research Award Winners of the 2019 European PRRS Research Award Winners of the 2019 European PRRS Research Award announced.
The little things The little things In 2009 Anna was diagnosed with scleroderma. For her, however, the disease is no reason to give up. On the contrary.
Approval for Aservo EquiHaler equine asthma therapy Approval for Aservo EquiHaler equine asthma therapy Boehringer Ingelheim receives approval for Aservo® EquiHaler®, industry first equine asthma therapy
BI increases commitments to sustainable development BI increases commitments to sustainable development At the World Health Summit 2021, Boehringer Ingelheim announces updates to its strategic approach to sustainable development
Partnership to further develop pet market in China Partnership to further develop pet market in China Boehringer Ingelheim invests in partnership to further develop the pet market in China, acquires a stake in New Ruipeng Group
A future without pills – could AI change the way we treat psychiatric diseases? A future without pills – could AI change the way we treat psychiatric diseases? Dr Cornelia Dorner-Ciossek talks about how her work with smartphone tech could transform how we treat mental illness.